D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea
· Delayed Price · Currency is KRW 61,500
+2,000 (3.36%)
Apr 29, 2025, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 637.08 billion as of April 29, 2025.
Market Cap
637.08B
Enterprise Value
616.31B
Revenue
11.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
61,500.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 637.08B, an increase of 67.85%. That is a compound annual growth rate of 68.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 637.08B | 24.04% |
| Dec 30, 2024 | 513.61B | 35.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.67T |
| Celltrion | 33.84T |
| ALTEOGEN | 19.67T |
| Yuhan | 8,608.63B |
| SK Biopharmaceuticals | 8,081.93B |
| HLB Co., Ltd. | 7,240.39B |
| Peptron | 4,063.06B |
| LigaChem Biosciences | 4,045.44B |